» Articles » PMID: 28775817

Eradication of Methicillin Resistant Biofilm by the Combined Use of Fosfomycin and β-chloro-L-alanine

Overview
Date 2017 Aug 5
PMID 28775817
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Biofilm formation is an important virulence factor for methicillin-resistant (MRSA). Fosfomycin is a borad-spectrum antibiotic with inhibitory effects on biofilm production and β-Chloro-L-alanine (β-CLA) is an amino acid analog. The aim of this study was to determine effect of the combination of fosfomycin and β-CLA on biofilm production by MRSA isolates. Also, the clonal relatedness of the isolates was evaluated.

Materials And Methods: To determine the ability of biofilm production by 42 MRSA isolates, microtiter plate method was used. Antibacterial activities of fosfomycin and β-CLA were investigated by determining MICs and MBCs. Antibiofilm activities were measured in the presence of sub-MIC concentrations of fosfomycin, β-CLA or a combination of both. RAPD-PCR was used for investigating the clonal relationship between isolates by the two specific primers.

Results: 21.4% of isolates were strong and 5% were moderate biofilm producers. The effect of fosfomycin plus β-CLA treatment on biofilm production was significantly different from non-treated, fosfomycin and β-CLA groups (p=0.00, 0.004 and 0.000 respectively). RAPD-PCR analysis revealed that the RAPD1 primer had more discriminatory power. The Sizes of RAPD-PCR bands ranged from 150 bp to 1500 bp and the number of bands varied from 1 to 13.

Conclusion: Clonal relatedness of isolates showed that the majority of biofilm producing isolates had identical pattern and only three isolates showed more than 80% similarity. The combination of fosfomycin and β-CLA could be introduced as an excellent mixture for eradication of MRSA biofilms in vitro.

Citing Articles

Healing wounds, defeating biofilms: in tackling MRSA infections.

Dubey A, Sharma M, Parul , Raut S, Gupta P, Khatri N Front Microbiol. 2023; 14:1284195.

PMID: 38116526 PMC: 10728654. DOI: 10.3389/fmicb.2023.1284195.


Anti-Staphylococcal Activities of and Essential Oils through ROS-Mediated Oxidative Stress.

Bowbe K, Salah K, Moumni S, Ashkan M, Merghni A Antibiotics (Basel). 2023; 12(2).

PMID: 36830178 PMC: 9952310. DOI: 10.3390/antibiotics12020266.


Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic Clinical Isolates.

Dzib-Baak H, Uc-Cachon A, Dzul-Beh A, Rosado-Manzano R, Gracida-Osorno C, Molina-Salinas G Trop Med Infect Dis. 2022; 7(9).

PMID: 36136646 PMC: 9505523. DOI: 10.3390/tropicalmed7090235.


Broad-Spectrum Antimicrobial Action of Cell-Free Culture Extracts and Volatile Organic Compounds Produced by Endophytic Fungi .

Santra H, Banerjee D Front Microbiol. 2022; 13:920561.

PMID: 35814705 PMC: 9260591. DOI: 10.3389/fmicb.2022.920561.


Cytotoxic Activity and Antibiofilm Efficacy of Biosynthesized Silver Nanoparticles against Methicillin-Resistant Strains Colonizing Cell Phones.

Merghni A, Lassoued M, Noumi E, Hadj Lajimi R, Adnan M, Mastouri M Can J Infect Dis Med Microbiol. 2022; 2022:9410024.

PMID: 35368519 PMC: 8975669. DOI: 10.1155/2022/9410024.


References
1.
Mobashery S, Johnston M . Inactivation of alanine racemase by beta-chloro-L-alanine released enzymatically from amino acid and peptide C10-esters of deacetylcephalothin. Biochemistry. 1987; 26(18):5878-84. DOI: 10.1021/bi00392a045. View

2.
Rio A, Garcia-de-la-Maria C, Entenza J, Gasch O, Armero Y, Soy D . Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus. Antimicrob Agents Chemother. 2015; 60(1):478-86. PMC: 4704234. DOI: 10.1128/AAC.02139-15. View

3.
Grinholc M, Wegrzyn G, Kurlenda J . Evaluation of biofilm production and prevalence of the icaD gene in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains isolated from patients with nosocomial infections and carriers. FEMS Immunol Med Microbiol. 2007; 50(3):375-9. DOI: 10.1111/j.1574-695X.2007.00262.x. View

4.
Michalopoulos A, Livaditis I, Gougoutas V . The revival of fosfomycin. Int J Infect Dis. 2011; 15(11):e732-9. DOI: 10.1016/j.ijid.2011.07.007. View

5.
Sulemankhil I, Ganopolsky J, Dieni C, Dan A, Jones M, Prakash S . Prevention and treatment of virulent bacterial biofilms with an enzymatic nitric oxide-releasing dressing. Antimicrob Agents Chemother. 2012; 56(12):6095-103. PMC: 3497171. DOI: 10.1128/AAC.01173-12. View